Vertex Pharmaceuticals (VRTX) — 8-K — Material Event

Vertex Pharmaceuticals is acquiring Crinetics Pharmaceuticals. The deal could lead to over $5 billion in annual revenue for Vertex. This announcement was made on July 6, 2026, and is reported under Form 8-K.

• •Vertex Pharmaceuticals is acquiring Crinetics Pharmaceuticals.
• •The deal could generate over $5 billion in annual revenue.
• •The announcement was made on July 6, 2026.
• •Completion of the acquisition depends on meeting certain conditions.

If successful, the acquisition will greatly increase Vertex's revenue and strengthen its product pipeline.